Search results

1222 results

Sorted by Date . Sort by Relevance

  1. Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer (TA628)

    Evidence-based recommendations on lorlatinib (Lorviqua) for previously treated ALK-positive advanced non-small-cell lung cancer in adults

  2. Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab (TA629)

    Evidence-based recommendations on obinutuzumab (Gazyvaro) with bendamustine for follicular lymphoma that has not responded or has progressed up to 6 months

  3. Brand guidelines

    This is an overview of the NICE brand identity incorporating who we are, what we do, and the values underpinning our work. Who we are NICE is the...

  4. Past appeals and decisions

    Down to Rejected appeals Cancelled appeals Past appeals TA ID Appraisal short title Appeal hearing date TA111 Alzheimer´s

  5. Topic selection

    How we select the subjects for development into information, advice and guidance

  6. Buy books, journals and databases

    The NICE Electronic and Print Content Framework Agreement - enables the NHS and other health and social care related organisations to buy medical and healthcare related content.

  7. Acute upper gastrointestinal bleeding

    Everything NICE has said on risk assessment and management of acute upper gastrointestinal bleeding in people 16 years and older in an interactive flowchart

  8. Transition from children's to adults' services

    Everything NICE has said on the transition from children's to adults' services for young people in health or social care in an interactive flowchart

  9. Multimorbidity

    Everything NICE has said on optimising care for people with 2 or more long-term health conditions in an interactive flowchart

  10. COVID-19 rapid guideline: acute kidney injury in hospital (NG175)

    The purpose of this guideline is to help healthcare professionals prevent, detect and manage acute kidney injury in adults in hospital with known or suspected COVID-19. This is important to improve outcomes and reduce the need for renal replacement therapy.

  11. Constipation

    Everything NICE has said on constipation in an interactive flowchart

  12. Food allergy in under 19s

    Everything NICE has said on diagnosing and assessing food allergy in children and young people in primary care and community settings in an interactive flowchart

  13. Managing medicines in care homes

    Everything NICE has said on systems and processes for managing medicines in care homes in an interactive flowchart

  14. COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital (NG173)

    The purpose of this guideline is to ensure the best antibiotic management of suspected or confirmed bacterial pneumonia in adults in hospital during the COVID-19 pandemic. This includes people presenting to hospital with moderate to severe community-acquired pneumonia and people who develop pneumonia while in hospital. It will enable services to make the best use of NHS resources.

  15. Chronic obstructive pulmonary disease

    Everything NICE has said on diagnosing and managing chronic obstructive pulmonary disease in people aged 16 and over in an interactive flowchart

  16. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response (NG169)

    The purpose of this guideline is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.

  17. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community (NG163)

    The purpose of this guideline is to provide recommendations for managing COVID-19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection.

  18. COVID-19 rapid guideline: critical care in adults (NG159)

    The purpose of this guideline is to maximise the safety of patients who need critical care during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

  19. Parkinson's disease

    Everything NICE has said on diagnosing and managing Parkinson's disease in adults in primary and secondary care in an interactive flowchart

  20. Metastatic spinal cord compression

    Everything NICE has said on detecting and managing metastatic spinal cord compression in adults with cancer in an interactive flowchart

  21. Cerebral palsy

    Everything NICE has said on cerebral palsy in an interactive flowchart

  22. Acute heart failure

    Everything NICE has said on diagnosing and managing acute heart failure in an interactive flowchart

  23. Neonatal parenteral nutrition

    Everything NICE has said on parenteral nutrition (intravenous feeding) for newborn babies in an interactive flowchart.

  24. COVID-19 rapid guideline: delivery of systemic anticancer treatments (NG161)

    The purpose of this guideline is to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandemic.

  25. Epilepsy

    Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

  26. Spasticity in children and young people

    Everything NICE has said on managing spasticity and co-existing motor disorders in children and young people in an interactive flowchart

  27. Multiple sclerosis

    Everything NICE has said on multiple sclerosis in an interactive flowchart

  28. Alcohol-use disorders

    Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

  29. COVID-19 rapid guideline: acute myocardial injury (NG171)

    The purpose of this guideline is to help healthcare professionals who are not cardiology specialists identify and treat acute myocardial injury and its cardiac complications in adults with known or suspected COVID-19 but without known pre-existing cardiovascular disease.